Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Can, M.
Right arrow Articles by Demirtas, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Can, M.
Right arrow Articles by Demirtas, S.
(Chest. 2006;129:233-237.)
© 2006 American College of Chest Physicians

Serum Cardiovascular Risk Factors in Obstructive Sleep Apnea*

Murat Can, MD; Serefden Açikgöz, MD; Görkem Mungan, MD; Taner Bayraktaroglu, MD; Erdem Koçak, MD; Berrak Güven, MD and Selda Demirtas, MD

* From Faculty Of Medicine (Drs. Can, Açikgöz, Mungan, and Güven), Department Of Biochemistry, and Faculty Of Medicine (Drs. Bayraktaroglu and Koçak), Department Of Internal Medicine, Karaelmas University, Zonguldak; and Faculty Of Medicine (Dr. Demirtas), Department Of Biochemistry, Ufuk University, Ankara, Turkey.

Correspondence to: Murat Can, MD, Karaelmas University, Faculty of Medicine, Department of Biochemistry, Zonguldak, Turkey; e-mail: drcanmurat{at}yahoo.com

Abstract

Background: Obstructive sleep apnea (OSA) patients have increased cardiovascular morbidity and mortality. The cardiovascular markers associated with OSA are currently not defined.

Objectives: The aims of this study were to determine whether OSA is associated with serum cardiac risk markers and to investigate the relationship between them.

Methods: Sixty-two male patients were classified into two groups with respect to apnea-hypopnea index (AHI): group 1, sleep apnea (n = 30), with AHI > 5; and group 2 (n = 32), with AHI < 5. We compared cardiovascular risk factors in both groups with control subjects (n = 30) without OSA (AHI < 1). Serum cholesterol, triglyceride, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein A-I, apolipoprotein B, lipoprotein (a), C-reactive protein (CRP), and homocysteine were measured. Statistical significance was assessed with analysis of variance at p < 0.05. In correlation analysis, Pearson correlation was used.

Results: There was no significant difference between group 1 and group 2 in total cholesterol, LDL-C, HDL-C, triglyceride, apolipoprotein A-I, apolipoprotein B, and lipoprotein (a). All of the M-mode echocardiographic parameters were in the normal reference range. Serum homocysteine and CRP levels were significantly increased in group 1 compared to group 2 (p < 0.05). Serum CRP values were increased in both group 1 and group 2 when compared with control subjects (p < 0.05). Serum homocysteine values were higher in group 1 than in control subjects (p < 0.05).

Conclusions: Our results show that OSA syndrome is associated not only with slight hyperhomocysteinemia but also with increased CRP concentrations. Increased plasma concentrations of homocysteine and CRP can be useful in clinical practice to be predictor of long-term prognosis for cardiovascular disease and the treatment of OSA.

Key Words: C-reactive protein • homocysteine • obstructive sleep apnea




This article has been cited by other articles:


Home page
ChestHome page
P. Steiropoulos, V. Tsara, E. Nena, C. Fitili, M. Kataropoulou, M. Froudarakis, P. Christaki, and D. Bouros
Effect of Continuous Positive Airway Pressure Treatment on Serum Cardiovascular Risk Factors in Patients With Obstructive Sleep Apnea-Hypopnea Syndrome
Chest, September 1, 2007; 132(3): 843 - 851.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. J. Olson and V. K. Somers
Modulation of cardiovascular risk factors by obstructive sleep apnea.
Chest, February 1, 2006; 129(2): 218 - 220.
[Full Text] [PDF]

eLetters:

Read all eLetters

Serum biomarkers of obstructive sleep apnea
H. Erhan Dincer, MD FCCP FAASM
Chest Online, 14 Mar 2006 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Chest Physicians.